First hurdles cleared with the FDA. Already approved in Europe, only a matter of time until US sales take off once they receive final clearance. At ~$90,000 a pop for the LVAD (bridge device for helping hearts pump blood until a new heart if found for patients).
Take advantage of quick short-term moves, and profit from price moves in any direction. Trade options under the direction of an expert guide. Try it now and get a 90-day unconditional money-back guarantee. 50% OFF for a limited time! Zacks Options Trader >>
Stock screening and chart patterns expert, Kevin Matras, combs through the best Zacks stock-picking strategies averaging +60% yearly gains to find stocks with charts showing they are ready to skyrocket. Chart Patterns Trader >>